HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

China Resources Related

956.845

-7.718-0.80%

Number of Gainers:2

Number of Losers:4

Number of Flat:1

PE:- -

High:964.712

Open:963.673

Low:953.824

Close:964.563

Volume:71.84M

Turnover:1.14B

Market Cap:500.92B

Float Cap:500.91B

Loading ...

China Resources Pharmaceutical Group Ltd. hielt außerordentliche Hauptversammlung ab

BRIEF-China Resources Pharmaceutical Updates On KPC Pharmaceuticals

KPC Pharmaceutical's 2025 Profit Slips 46%

MT Newswires Live

Tasly Pharmaceutical Reports 11.05 Billion Yuan Net Profit for 2025, Marking 15.68% Year-on-Year Growth

CR Sanjiu Posts 14.53% Revenue Growth Under China Resources Pharmaceutical Group

CR Sanjiu steigert Umsatz um 14,53 Prozent und bleibt Tochtergesellschaft der China Resources Pharmaceutical Group

Tasly Pharmaceutical Affiliate Posts Preliminary 2025 Results Under China Resources Pharmaceutical Group

Tasly Pharmaceutical meldet vorläufige Jahreszahlen 2025 als assoziiertes Unternehmen von China Resources Pharmaceutical Group

China Resources Pharmaceutical Group Ltd - FY Prelim Net Profit Attributable for Kpc Pharmaceuticals RMB349.9 Mln

THOMSON REUTERS

China Resources Pharmaceutical Group Ltd. meldet Gewinnrückgang bei assoziiertem Unternehmen KPC Pharmaceuticals

China Resources Beer (Holdings) Stock Sheds 1.7% in Hong Kong

China Resources Mixc Lifestyle Services Board to Consider Annual Results and Dividend

Goldman Sachs Adds MAO GEPING to Asia-Pacific Conviction Buy List, Removes CHINA RES LAND

CR BLDG MAT TEC Shares Surge Over 4% Following Profit Alert, Anticipates Annual Profit Attributable to Shareholders Could Rise Up to Approximately 135%

China Resources Building Materials Technology Forecasts Up to 135% Boost in 2025 Profit

MT Newswires Live

China Resources Building Materials erwartet Gewinnanstieg um bis zu 135 Prozent

China Resources Building Materials Expects 115-135% Profit Surge for 2025

China Resources Cement - Expected Result Due to Lower Costs and Reduction of Impairment Loss in FY

THOMSON REUTERS

China Resources Cement - Profit for 2025 Expected to Increase by 115% to 135%

THOMSON REUTERS

China's Property Market Could Be Bottoming Out -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1570/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1570","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1570\",,,,,undefined,":{"symbol":"BK1570","market":"HK","secType":"PLATE","nameCN":"China Resources Related","latestPrice":956.8451,"timestamp":1770365282315,"preClose":964.56287,"halted":0,"volume":71843584,"delay":0,"changeRate":-0.008001,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-7.717773,"latestTime":"02-06 16:00:00","open":963.6734,"high":964.7115,"low":953.82416,"amount":1136551394,"amplitude":0.011287,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"pbRate":0.796318,"peRate":8.770493,"turnoverRate":0.002081,"increases":2,"decrements":4,"flats":1,"marketCap":500918035200,"floatMarketCap":500913772288},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1570\",,,,,undefined,":{"symbol":"BK1570","high":964.7115,"amplitude":0.011287,"preClose":964.56287,"low":953.82416,"pbRate":"0.796318","latestPrice":956.8451,"volume":71843584,"delay":0,"open":963.6734,"prevYearClose":885.673,"prevWeekClose":936.351,"prevMonthClose":936.351,"prevQuarterClose":885.673,"fiveDayClose":936.351,"twentyDayClose":919.364,"sixtyDayClose":953.335,"secType":"PLATE","market":"HK","turnoverRate":0.002081,"peRate":8.770493,"marketCap":500918035200,"floatMarketCap":500913772288,"timestamp":1770365282315,"nameCN":"China Resources Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1570\",,,,undefined,":{"bkCode":"BK1570","up":2,"down":4,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1570\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609591236","title":"China Resources Pharmaceutical Group Ltd. hielt außerordentliche Hauptversammlung ab","url":"https://stock-news.laohu8.com/highlight/detail?id=2609591236","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609591236?lang=en_us&edition=fundamental","pubTime":"2026-02-06 22:19","pubTimestamp":1770387580,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Ltd. hat am 6. Februar 2026 eine auerordentliche Hauptversammlung abgehalten. Die vorgeschlagenen Punkte – die Genehmigung fortlaufender verbundener Transaktionen im Rahmen des Sales Framework Agreement 2026/2028 sowie die nderungen der Satzung – wurden jeweils angenommen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL6dLYqM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03320","BK1570"],"gpt_icon":0},{"id":"2609599250","title":"BRIEF-China Resources Pharmaceutical Updates On KPC Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2609599250","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609599250?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:58","pubTimestamp":1770386332,"startTime":"0","endTime":"0","summary":"BRIEF-China Resources Pharmaceutical Updates On KPC PharmaceuticalsFeb 6 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:FY PRELIM NET PROFIT ATTRIBUTABLE FOR KPC PHARMACEUTICALS RMB349.9 MILLIONFurther company coverage: 3320.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z20L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0239","03320","BK1570","BK0188","BK0028","600422","BK1191"],"gpt_icon":0},{"id":"2609953235","title":"KPC Pharmaceutical's 2025 Profit Slips 46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609953235","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609953235?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:54","pubTimestamp":1770382498,"startTime":"0","endTime":"0","summary":"KPC Pharmaceutical  recorded an attributable profit of 349.9 million yuan for the year 2025, down 46% from 648.1 million yuan a year prior, according to a Friday Hong Kong bourse filing by parent China Resources Pharmaceutical Group .Basic EPS stood at 0.46 yuan for the year, down from 0.86 yuan in the last corresponding period.Operating revenue for the period slipped 22% to 6.58 billion yuan from 8.4 billion yuan in the year-ago period.The downbeat results came about amid a decline in product sales and gross profit margin.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","600422","BK0028","BK1570","BK0239","BK0188","BK0060","03320"],"gpt_icon":0},{"id":"1114832908","title":"Tasly Pharmaceutical Reports 11.05 Billion Yuan Net Profit for 2025, Marking 15.68% Year-on-Year Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1114832908","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114832908?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:46","pubTimestamp":1770381977,"startTime":"0","endTime":"0","summary":"CHINARES PHARMA (03320) has released the unaudited preliminary financial data for Tasly Pharmaceutical Group Co.,Ltd. for the year ended December 31, 2025. Tasly Pharmaceutical achieved total...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","09939","BK0239","BK1515","BK1570","159938","BK0196","BK1161","BK0183","BK0012","BK0028","600535","03320","BK0188"],"gpt_icon":0},{"id":"2609659362","title":"CR Sanjiu Posts 14.53% Revenue Growth Under China Resources Pharmaceutical Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2609659362","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609659362?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:37","pubTimestamp":1770381463,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Ltd. holds a 63.22% indirect stake in China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. , making it a subsidiary. For the year ended 31 December 2025, CR Sanjiu reported unaudited preliminary financial results with total operating revenue of RMB31.629 billion, up 14.53% year-on-year, and net profit attributable to shareholders of the listed company of RMB3.422 billion, an increase of 1.60% compared to the previous year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 06, 2026, and is solely res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL3D6W11:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000999","BK0175","BK1191","BK0028","03320","BK0196","BK0012","BK0060","BK0183","BK0188","BK0010","BK1570","BK0239","BK0185"],"gpt_icon":0},{"id":"2609625593","title":"CR Sanjiu steigert Umsatz um 14,53 Prozent und bleibt Tochtergesellschaft der China Resources Pharmaceutical Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2609625593","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609625593?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:37","pubTimestamp":1770381463,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL3V5xL8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0239","BK0010","000999","BK0175","BK0188","03320","BK0185","BK0060","BK0183","BK1191","BK1570","BK0012","BK0196"],"gpt_icon":0},{"id":"2609935015","title":"Tasly Pharmaceutical Affiliate Posts Preliminary 2025 Results Under China Resources Pharmaceutical Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2609935015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609935015?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:34","pubTimestamp":1770381292,"startTime":"0","endTime":"0","summary":"Tasly Pharmaceutical Group Co., Ltd., an affiliate of China Resources Pharmaceutical Group Ltd., released its unaudited preliminary financial results for the year ended 31 December 2025. China Resources Pharmaceutical Group Ltd. holds approximately a 28% equity interest in Tasly Pharmaceutical through its non-wholly-owned subsidiary, China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. In 2025, Tasly Pharmaceutical became a member of the CR Sanjiu group, completing a \"100-day integration\" and accelerating resource integration. For the year, Tasly Pharmaceutical reported total operating revenue of RMB 8,236.48 million, a 3.08% decrease year-on-year, and net profit attributable to shareholders of RMB 1,105.40 million, an increase of 15.68%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL5Fc3Bw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","BK0010","600535","BK0196","BK1570","BK0028","BK0183","000999","BK0185","BK0012","BK0188","BK0239","BK0060","BK0175","BK1191"],"gpt_icon":0},{"id":"2609593509","title":"Tasly Pharmaceutical meldet vorläufige Jahreszahlen 2025 als assoziiertes Unternehmen von China Resources Pharmaceutical Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2609593509","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609593509?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:34","pubTimestamp":1770381292,"startTime":"0","endTime":"0","summary":"Tasly Pharmaceutical meldet vorlufige Jahreszahlen 2025 als assoziiertes Unternehmen von China Resources Pharmaceutical Group. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL3kM8mT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK0012","BK0183","BK0175","BK0185","BK0010","000999","BK0239","BK0060","BK0188","BK0028","600535","BK0196","BK1570","03320"],"gpt_icon":0},{"id":"2609259834","title":"China Resources Pharmaceutical Group Ltd -  FY Prelim Net Profit Attributable for Kpc Pharmaceuticals RMB349.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2609259834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609259834?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:04","pubTimestamp":1770379486,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z20L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0188","BK0060","BK1191","600422","03320","BK0028","BK0239","BK1570"],"gpt_icon":0},{"id":"2609772560","title":"China Resources Pharmaceutical Group Ltd. meldet Gewinnrückgang bei assoziiertem Unternehmen KPC Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2609772560","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609772560?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:00","pubTimestamp":1770379238,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL6C2dvs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","BK0010","BK0183","BK1570","BK0175","BK0060","BK1191","BK0239","BK0196","600422","BK0185","BK0012","BK0188","000999","BK0028"],"gpt_icon":0},{"id":"2609563651","title":"China Resources Beer (Holdings)  Stock Sheds 1.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2609563651","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609563651?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:32","pubTimestamp":1770366720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of China Resources Beer  Co. Ltd. slid 1.7% to 27.22 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.2% to 26559.95.The stock's fall snapped a four-day winning streak.China Resources Beer  Co. Ltd. closed 12% below its 52-week high of HK$31.05, which the company reached March 19.Trading volume totaled 14.3 million shares, compared to the 50-day average of 10.9 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201612.USD","BK1570","LU0328353924.USD","SG9999006514.SGD","BK1589","LU1720050803.USD","IE00B0169L03.USD","80291","BK1180","IE0008369823.USD","IE00B5MMRT66.SGD","LU1328615791.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","IE0008368742.USD","BK1578","LU1023057109.AUD","LU1769817179.HKD","IE00B29SXG58.USD","CRHKY","LU1794554557.SGD","BK1510","00291","BK1521","BK1604","LU0359202008.SGD","BK1583","IE0031814852.USD","LU1769817096.USD","IE00B031HY20.USD"],"gpt_icon":0},{"id":"2609371271","title":"China Resources Mixc Lifestyle Services Board to Consider Annual Results and Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2609371271","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609371271?lang=en_us&edition=fundamental","pubTime":"2026-02-05 19:47","pubTimestamp":1770292023,"startTime":"0","endTime":"0","summary":"China Resources Mixc Lifestyle Services Ltd. has announced that its board of directors will hold a meeting on Friday, 27 March 2026 to consider and approve the final results of the company and its subsidiaries for the year ended 31 December 2025, as well as to discuss the potential payment of dividends.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Mixc Lifestyle Services Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL3KQY23:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0287142896.SGD","LU2088747998.USD","LU0067412154.USD","LU0082770016.USD","LU0880133367.SGD","LU0456827905.SGD","LU0501845795.SGD","SG9999014674.SGD","LU0370786039.SGD","LU0979878070.USD","LU0048597586.USD","LU0516423091.SGD","LU0164939612.USD","BK1583","LU1023057109.AUD","LU1366334651.USD","LU2088748293.HKD","LU0251144936.SGD","LU0620787316.HKD","LU1993786604.SGD","LU2088747725.USD","01109","LU0605514214.HKD","LU1242518931.SGD","LU0051755006.USD","LU0359202008.SGD","BK1570","LU0516422366.SGD","BK1258","LU0738912210.USD","01209","BK1521","BK1542","LU0082770016.SGD","LU0594300179.USD","HK0000320264.USD","LU0516422952.EUR","BK1589","LU1152091168.USD","HK0000320223.HKD","LU3063872942.SGD","SG9999009997.SGD","LU0048580855.USD","BK1240","LU0791591158.USD","BK1229","LU0173614495.USD","LU0359201612.USD","LU0414403682.SGD","SG9999010052.SGD"],"gpt_icon":0},{"id":"1120816188","title":"Goldman Sachs Adds MAO GEPING to Asia-Pacific Conviction Buy List, Removes CHINA RES LAND","url":"https://stock-news.laohu8.com/highlight/detail?id=1120816188","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120816188?lang=en_us&edition=fundamental","pubTime":"2026-02-05 15:36","pubTimestamp":1770276985,"startTime":"0","endTime":"0","summary":"Goldman Sachs has released its latest Asia-Pacific \"Directors' Cut\" Conviction Buy list. The firm has added MAO GEPING (01318) to the selection. Simultaneously, DISCO (6146.JP), CHINA RES LAND...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0738912210.USD","LU0880133367.SGD","HK0000306701.USD","LU1366334578.USD","LU2088748376.SGD","LU0348767384.USD","LU1366334651.USD","HK0000320223.HKD","LU0594300179.USD","LU0251144936.SGD","LU0791591158.USD","LU1023057109.AUD","BK1207","LU3063872942.SGD","BK1521","BK1570","LU0348766576.USD","LU1993786604.SGD","LU2088748020.USD","LU0414403682.SGD","LU0516423174.USD","LU0501845795.SGD","LU1807302812.USD","SG9999010078.USD","LU0417516902.SGD","SG9999014674.SGD","IE0008368742.USD","HK0000306685.HKD","HK0000320264.USD","LU2088747998.USD","01109","LU0605514214.HKD","LU1008478684.HKD","LU1152091168.USD","LU0516422366.SGD","LU0173614495.USD","LU0650527681.SGD","BK1240","LU0359202008.SGD","LU0048597586.USD","LU0370786039.SGD","LU0791590937.USD","LU1152091754.HKD","SG9999010052.SGD","LU1242518931.SGD","LU0067412154.USD","LU0516423091.SGD","BK1555","LU0287142896.SGD","LU1960683339.HKD","SG9999009997.SGD","LU0048580855.USD","01318","LU0594300419.USD","LU2088748293.HKD","LU0348825331.USD","LU0516422952.EUR","LU1880383366.USD","LU2088747725.USD","LU0979878070.USD","LU0516422440.USD","LU0359201612.USD","BK1589","LU0072913022.USD","LU1242518857.USD"],"gpt_icon":0},{"id":"1142786574","title":"CR BLDG MAT TEC Shares Surge Over 4% Following Profit Alert, Anticipates Annual Profit Attributable to Shareholders Could Rise Up to Approximately 135%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142786574","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142786574?lang=en_us&edition=fundamental","pubTime":"2026-02-05 11:00","pubTimestamp":1770260436,"startTime":"0","endTime":"0","summary":"Shares of CR BLDG MAT TEC (01313) climbed more than 4% after the company issued a positive profit alert. At the time of writing, the stock was up 4.47%, trading at HK$1.87, with a turnover of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01313","BK1570","SG9999003461.SGD","BK1563","LU0274383008.USD","BK1507","SG9999002950.SGD","BK1589","BK1135","BK1594"],"gpt_icon":0},{"id":"2608368195","title":"China Resources Building Materials Technology Forecasts Up to 135% Boost in 2025 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2608368195","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608368195?lang=en_us&edition=fundamental","pubTime":"2026-02-04 19:09","pubTimestamp":1770203372,"startTime":"0","endTime":"0","summary":"China Resources Building Materials Technology  expects a 115% to 135% rise in attributable profit for the year 2025 from 210.9 million yuan a year prior, according to a Wednesday Hong Kong bourse filing.The cement manufacturer attributed the forecast to a decline in costs and impairment loss.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0274383008.USD","SG9999002950.SGD","BK1594","SG9999003461.SGD","BK1135","BK1570","BK1563","01313","BK1507","BK1589"],"gpt_icon":0},{"id":"2608352798","title":"China Resources Building Materials erwartet Gewinnanstieg um bis zu 135 Prozent","url":"https://stock-news.laohu8.com/highlight/detail?id=2608352798","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608352798?lang=en_us&edition=fundamental","pubTime":"2026-02-04 18:01","pubTimestamp":1770199274,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Building Materials Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL8p8zPF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01313","SG9999002950.SGD","SG9999003461.SGD","BK1563","LU0274383008.USD","BK1594","BK1589","BK1507","BK1570","BK1135"],"gpt_icon":0},{"id":"2608352797","title":"China Resources Building Materials Expects 115-135% Profit Surge for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2608352797","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608352797?lang=en_us&edition=fundamental","pubTime":"2026-02-04 18:01","pubTimestamp":1770199274,"startTime":"0","endTime":"0","summary":"China Resources Building Materials Technology Holdings Ltd. has announced that, based on preliminary assessment of its unaudited consolidated management accounts, profit attributable to owners of the company for the year ended 31 December 2025 is expected to increase by approximately 115% to 135% compared with RMB210,863,000 recorded for the year ended 31 December 2024. The significant improvement in business performance is primarily attributed to lower costs and a reduction of impairment loss during 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Building Materials Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong K","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL4K2hkm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1563","BK1589","BK1507","SG9999003461.SGD","SG9999002950.SGD","01313","BK1135","BK1594","LU0274383008.USD","BK1570"],"gpt_icon":0},{"id":"2608352757","title":"China Resources Cement - Expected Result Due to Lower Costs and Reduction of Impairment Loss in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2608352757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608352757?lang=en_us&edition=fundamental","pubTime":"2026-02-04 18:00","pubTimestamp":1770199255,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nFWN3Z00FK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01313","BK1135","SG9999003461.SGD","BK1563","BK1594","BK1570","SG9999002950.SGD","LU0274383008.USD","BK1589","BK1507"],"gpt_icon":0},{"id":"2608235273","title":"China Resources Cement - Profit for 2025 Expected to Increase by 115% to 135%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608235273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608235273?lang=en_us&edition=fundamental","pubTime":"2026-02-04 18:00","pubTimestamp":1770199255,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nFWN3Z00FK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01313","SG9999003461.SGD","LU0274383008.USD","BK1570","BK1594","BK1563","BK1135","SG9999002950.SGD","BK1589","BK1507"],"gpt_icon":0},{"id":"2608435601","title":"China's Property Market Could Be Bottoming Out -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2608435601","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608435601?lang=en_us&edition=fundamental","pubTime":"2026-02-04 16:35","pubTimestamp":1770194100,"startTime":"0","endTime":"0","summary":"0835 GMT - China's property market could be bottoming out after secondary market transactions in January showed improvements in some cities, say DBS Group Research analysts in commentary. New secondary property listings in cities including Shanghai also declined, which could indicate stabilizing home-buyer confidence as sellers aren't rushing to offload properties, the analysts say. However, the soft primary sales market suggests sustained recovery has yet to happen, they add. DBS expects physical market weakness to persist into 1Q, partly thanks to a high base. Policy tailwinds, such as Shanghai's second-home repurchase program for certain properties, could also drive share-price performance ahead of the earnings season, the bank says. China Overseas Grand Oceans, China Overseas Land & Investment and China Resources Land could benefit from solid landbank replenishment, DBS says. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0287142896.SGD","LU0955669360.SGD","LU0441854154.USD","LU1363072403.SGD","LU1807302812.USD","LU0251143029.SGD","SG9999003800.SGD","LU0823038988.USD","LU0979878070.USD","LU0516423091.SGD","LU2238330802.EUR","LU0588545904.SGD","LU0011963245.USD","SG9999016042.SGD","LU1366334651.USD","CRBJY","LU0251144936.SGD","LU2506951958.HKD","LU1956131251.USD","BK6523","LU1211504680.USD","SG9999004360.SGD","SG9999011175.SGD","LU0791590937.USD","LU0516422366.SGD","LU1130305938.SGD","LU0762540952.USD","IE00BZ08YS42.EUR","LU0878005551.USD","LU2088748020.USD","LU0702159699.USD","HK0000306685.HKD","HK0000320264.USD","LU0326948709.USD","LU0886674414.USD","LU0873338254.USD","LU1497733557.USD","LU3063872942.SGD","SGXZ27511609.SGD","SG9999009997.SGD","IE00BVYPNQ40.USD","SG9999002414.USD","LU0173614495.USD","LU0650527681.SGD","LU0588545490.SGD","SGXZ24219693.SGD","LU0441851309.USD","HK0000306701.USD","LU0048573645.USD","LU0823397285.USD","LU0261945553.USD","LU0823397103.USD","LU1166156734.SGD","LU0823039010.USD","LU0823417653.USD","LU0235996351.USD","LU1770036033.HKD","LU0048597586.USD","SG9999001226.SGD","LU0084288322.USD","IE00BKZH1Z71.USD","LU1023057109.AUD","LU0543330483.HKD","LU0882747503.HKD","LU0594300419.USD","LU0672654166.SGD","LU1634259557.SGD","LU1282649141.HKD","LU1993786604.SGD","01109","LU0577902454.USD","LU0577902298.EUR","LU0577902538.SGD","IE00BZ08YT58.USD","LU0205439572.USD","SG9999008742.SGD","LU0605514214.HKD","LU0630378429.USD","LU1634259391.SGD","SG9999001135.SGD","CAOVY","LU0831103253.SGD","LU0594300179.USD","LU0823413660.USD","LU0516422952.EUR","LU0315179316.USD","LU0675040207.SGD","LU0737861269.HKD","BK1589","LU2237957811.SGD","SG9999006266.SGD","LU0096374516.USD","LU0315178854.USD","LU0702159343.USD","LU0128522157.USD","LU0823417737.USD","LU0865486749.SGD","SG9999007991.SGD","LU1366334578.USD","SG9999002620.SGD","LU0359201612.USD","SG9999002604.SGD","LU0072913022.USD","LU0831093199.SGD","LU0488056044.USD","LU0880133367.SGD","SG9999014674.SGD","LU0345775950.USD","LU1497734951.SGD","LU0029875118.USD","LU0878004406.USD","LU0971096721.USD","SGXZ58947870.SGD","LU0348825331.USD","LU0648948544.HKD","LU2088748293.HKD","LU0384037296.USD","SG9999003826.SGD","BK6516","LU0329678170.USD","LU0955648018.USD","SG9999004220.SGD","LU1242518931.SGD","LU1282649810.SGD","LU0188438112.USD","LU0359202008.SGD","LU1504937902.USD","LU1152091754.HKD","LU2237957902.USD","LU1008478684.HKD","SG9999002406.SGD","SG9999009443.AUD","IE00BGHQDM52.EUR","SG9999002562.SGD","03121","SG9999013460.SGD","BK1521","LU0898667661.SGD","LU0588545730.USD","LU1839390173.USD","LU1522347837.USD","LU0516423174.USD","LU1152091168.USD","HK0000320223.HKD","LU2257852520.SGD","LU0048580855.USD","LU0791591158.USD","BK6112","IE0031814969.USD","LU1960683339.HKD","LU0417516902.SGD","SGXZ43160589.SGD","LU0577902371.SGD","LU0577902611.USD","SG9999010052.SGD","LU2088747998.USD","LU0067412154.USD","SG9999000475.SGD","LU0501845795.SGD","LU0950375773.USD","LU0532188223.SGD","IE00BVYPNP33.GBP","LU0370786039.SGD","LU2506952097.USD","LU0737861772.HKD","SG9999010078.USD","LU0823413587.USD","LU2506952170.USD","LU0192582467.USD","SG9999014492.USD","IE00BZ08YR35.GBP","LU1282649067.USD","LU2506951875.HKD","LU2088747725.USD","LU0516422440.USD","LU1497733631.SGD","SG9999002679.SGD","IE0008368742.USD","SG9999013353.USD","SG9999013486.USD","SG9999014484.SGD","SG9999005177.SGD","SG9999013478.USD","LU0061477393.USD","LU0955623706.USD","BK1570","SG9999014302.SGD","SG9999000459.SGD","LU1880383366.USD","00688","LU0738912210.USD","LU0210637038.USD","SG9999001127.SGD","LU0261947096.USD","LU1242518857.USD","LU2088748376.SGD","SG9999001846.SGD","BK1240","SG9999001903.USD","LU0329678337.USD","SG9999000343.SGD","LU0211331839.USD","BK1555","LU0414403682.SGD","LU0345776255.USD","00081","LU0557290698.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}]}}